From: Abstracts from the 8th Drug Hypersensitivity Meeting (DHM)
Total number of patients | 404 with HR-test |
---|---|
Males | 171 |
Females | 233 |
M:F-ratio | 0.73 |
Age, mean, median, [range], years | 50.16, 51.39, [range 2.1–85.1 years] |
Ethnicity | Â |
 Caucasian | 393 |
 Middle eastern | 3 |
 Black race | 1 |
 Asian | 5 |
 Other | 1 |
Current tobacco use, n | Â |
 Yes | 70 |
 No | 188 |
 Unknown | 146 |
Positive family history of AE, n | 31 |
Number of HR-tests, total | 404 |
 Positive | 39 (9.7%) |
 Negative | 360 (89.1%) |
 Unknown result | 5 (0.5%) |
Comorbidities: | Â |
 Diabetes mellitus | 32 |
 Hypertension | 115 |
 Ischemic heart disease | 24 |
 Heart failure | 7 |
 Atopic dermatitis | 21 |
 Allergic rhinitis | 56 |
 Asthma | 42 |
 Other respiratory disease | 4 |
Follow-up time, mean; [range], weeks | 66.4; [0–675.1 weeks] |
Reported effect of antihistamines, n | 270 |
Reported effect of corticosteroids, n | 165 |
Hospitalized due AE, n (%) | 138 (34.2%) |
ER visits due to AE, n (%) | 144 (35.6%) |